KLCM Portfolio Rebalance
KLCM Advisors Actively Rebalances Portfolio, Boosts Lam Research and Adds ADP in Q1
Anonymous
Key Points
1
Lam Research has a high institutional stake, with 84.61% of its stock owned by institutional investors, highlighting broad professional involvement in the name.
2
Analysts weighed in on Lam Research in the first quarter, with New Street Research raising its target to 280 (neutral), Goldman Sachs reiterating a Buy with a 290 target, Stifel Nicolaus lifting its objective to 425 (Buy), and Oppenheimer maintaining an Outperform rating with a 400 target (up from 330).
3
Bristol Myers Squibb (BMY) is the 15th largest holding in KLCM’s portfolio, illustrating its role as a mid-sized position within the overall mix.
4
Truist Financial (TFC) is the 17th largest holding in KLCM’s portfolio, comprising about 1.4% of the overall allocation and valued at roughly $16.25 million.
5
In Texas Pacific Land, while KLCM trimmed its stake by 11.9%, other institutions increased their positions, notably Bar Harbor Wealth Management (+195.1% to 36,873 shares) and Stratos Wealth Partners (+212.9% to 18,211 shares).
KLCM Advisors Inc. boosted its stake in Lam Research by 11% in the first quarter, adding 1,646 shares to reach a total of 16,663 shares worth about $3.56 million, according to Watchlist News. The move signals growing confidence in semiconductor equipment as the firm actively reshuffles holdings across tech, finance, and healthcare.
At the same time, KLCM made a fresh bet on payroll giant Automatic Data Processing, picking up 9,991 shares worth roughly $2.03 million. The new position came alongside a mix of cuts and additions across the portfolio, showing a firm in active rebalancing mode.
Lam Research Gains Ground With Analyst Backing
KLCM's 11% increase in Lam Research comes as Wall Street analysts turn more bullish on the chipmaker. Goldman Sachs reiterated a Buy rating with a $290 price target. Stifel Nicolaus lifted its target to $425, also with a Buy rating. Oppenheimer kept its Outperform rating and raised its target from $330 to $400, according to Watchlist News.
Institutional investors broadly share KLCM's enthusiasm. A full 84.61% of Lam Research stock is held by institutional investors. New Street Research also weighed in, raising its target to $280 with a neutral stance. The stock has wide professional support across the board.
Bristol Myers and Truist Positions Reflect Portfolio Priorities
KLCM trimmed its Bristol Myers Squibb stake by 6.2%, selling down to 300,430 shares valued at about $18.22 million, per Watchlist News. Bristol Myers is the firm's 15th largest holding. It makes up roughly 1.5% of the total portfolio. The cut suggests a modest pullback, not an exit.
Meanwhile, KLCM added to its Truist Financial position, growing it by 6.0% to 353,458 shares worth about $16.25 million. Truist ranks as the 17th largest holding at about 1.4% of the portfolio. The increase shows the firm still sees value in regional banking names despite a choppy rate environment.
Texas Pacific Land Stake Cut as Others Buy In
KLCM reduced its Texas Pacific Land position by 11.9%, bringing its total to 25,990 shares worth about $12.33 million, according to Watchlist News. The cut stands out in a natural resources name that other institutions were actively buying. It shows KLCM taking a different view from the crowd.
Bar Harbor Wealth Management grew its Texas Pacific Land stake by 195.1% to 36,873 shares. Stratos Wealth Partners went even further, up 212.9% to 18,211 shares. While peers piled in, KLCM chose to scale back — a clear sign of selective, conviction-driven portfolio management.
New ADP Position Rounds Out a Busy Quarter
KLCM's new 9,991-share position in Automatic Data Processing totals roughly $2.03 million. ADP is a payroll and human resources software giant. The purchase fits a broader pattern of adding large, stable tech-adjacent businesses to the portfolio, per Ticker Report.
The firm also cut its U.S. Bancorp stake by 15.0%, down to 111,552 shares, according to Ticker Report. Taken together, KLCM's Q1 moves show a firm pruning financial exposure in some spots while building it in others. The quarter was defined by deliberate, targeted shifts — not broad sweeping changes.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
12
Articles
7
Reach
19
A
AnonymousAuthor
